Insider sales are routine and negligible relative to market cap. The strong Q1 earnings and raised guidance are the dominant signal. Monitor for any follow-on insider selling in the next 30 days; if sales accelerate beyond 0.1% of market cap, reassess.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 7 $107.91entry
- T+1 · 6mo ago +0.03%α −0.80% · $107.94
- T+5 · 6mo ago −9.03%α −10.53% · $98.17
- T+20 · 6mo ago −15.08%α −18.21% · $91.64
- T+60 · 4mo ago −3.98%α −7.82% · $103.61
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, following the company's strong Q1 2026 earnings beat and raised guidance. The sales are modest relative to the $2.5B market cap (0.04%) and are likely routine portfolio rebalancing after a period of strong stock performance, not a bearish signal.
Key Financial Metrics
Key Facts
- Two directors sold a total of $994K in open-market sales on May 7, 2026.
- Sales represent 0.04% of LMAT's $2.5B market cap, trivial in size.
- Q1 2026 EPS of $0.68 beat consensus by 3%, revenue of $66.6M was in line.
- Full-year 2026 guidance raised: operating income midpoint to $79.8M, EPS to $3.00.
- Both sales were accompanied by derivative exercises at much lower strike prices, indicating the sales were likely to cover tax obligations or lock in gains from options.
Financial Impact
Total insider sales of $994K, or 0.04% of market cap, immaterial.
Risk Factors
- Insider sales could accelerate if the stock continues to rally, creating a perception of top-picking.
- No material risk identified from this cluster alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LMAT-1778533892241 |
Track record
14 reports on LMAT
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.08% at T+20 after the May 7, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bearish 6/10 Entry $83.49 to $77.65 Now $77.01 +7.76% ▲ +6.99% +10.29% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $80.60 to $79.02 Now $77.01 −4.45% ▼ −1.96% −1.37% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $80.82 to $84.45 Now $77.01 −4.71% ▲ +4.49% +4.40% vs SPY
- Aug 27, 202611w ago Press Release Neutral 2/10 Entry $80.45 to $80.67 Now $77.01 −4.28% ▲ +0.27% +0.16% vs SPY
- Jul 14, 202617w ago Press Release Neutral 1/10 Entry $99.79 Now $77.01 −22.83% No price data
- May 7, 202627w ago Insider Cluster Bearish 4/10 Entry $107.91 to $98.17 Now $77.01 +28.63% ▲ +9.03% +10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 2/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 3/10 Viewing Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 5, 202627w ago 8-K Bullish 7/10 Entry $110.22 to $97.22 Now $77.01 −30.13% ▼ −11.79% −12.93% vs SPY
- Apr 14, 202630w ago DEFA14A Neutral 3/10 Entry $117.39 to $111.90 Now $77.01 −34.40% ▼ −4.68% −6.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers